Author/Authors :
nematbakhsh, mehdi isfahan university ofmedical sciences - department of physiology, Isfahan, iran , nematbakhsh, mehdi isfahan university of medical sciences - water and electrolytes research center, Isfahan, iran , nematbakhsh, mehdi isfahan institute of basic and applied sciences research, Isfahan, iran , ashrafi, farzaneh isfahan university of medical sciences - department of internal medicine, hematology and medical oncology section, Isfahan, iran , ashrafi, farzaneh isfahan university of medical sciences - water and electrolytes research center, Isfahan, iran
Abstract :
letter to editor: Blood pressure alteration and angiotensin receptor blocker treatment may influence cisplatin‑induced nephrotoxicity. Komaki et al.[1] in their cohort study concluded that “Lower blood pressure and the use of renin‑angiotensin system inhibitors were associated with the incidence of cisplatin nephrotoxicity” while Liu et al.[2] in their study mentioned that “Angiotensin‑converting enzyme inhibitor/angiotensin receptor blocker usage and administration of a single application of cisplatin were independent risk factors for cisplatin‑induced acute kidney injury in the elderly.”
